Survey: Not enough resources available to meet the needs for pediatric preventive cardiology care

More adolescents and teens are developing health conditions that may increase their risk of premature cardiovascular disease in adulthood, therefore, early screening, diagnosis and multidisciplinary care are vital.

NUC-7738 by NuCana for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma): Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

October 27, 2023

Pathology: Mindpeak, Proscia Partner To Improve Cancer Diagnosis

What You Should Know: Mindpeak, a leading provider of artificial intelligence (AI) for pathology, and Proscia®, a leading provider of digital and computational pathology solutions, have announced

June 20, 2023

Ibogaine Advocates Seek Ohio Opioid Settlement Funds Following Failure in Kentucky – Psychedelic Alpha

As we mentioned in our coverage of the Kentucky effort, bringing a drug through the FDA approval process is expensive, with costs often measured in

February 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.